DK2129391T3 - Diagnostisk fremgangsmåde - Google Patents

Diagnostisk fremgangsmåde

Info

Publication number
DK2129391T3
DK2129391T3 DK08759218.4T DK08759218T DK2129391T3 DK 2129391 T3 DK2129391 T3 DK 2129391T3 DK 08759218 T DK08759218 T DK 08759218T DK 2129391 T3 DK2129391 T3 DK 2129391T3
Authority
DK
Denmark
Prior art keywords
hbp
diagnostic procedure
individual
level
ratio
Prior art date
Application number
DK08759218.4T
Other languages
English (en)
Inventor
Lars Bjorck
Bertil Christensson
Heiko Herwald
Adam Linder
Per Akesson
Original Assignee
Hansa Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38331957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2129391(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hansa Medical Ab filed Critical Hansa Medical Ab
Application granted granted Critical
Publication of DK2129391T3 publication Critical patent/DK2129391T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
DK08759218.4T 2007-06-12 2008-06-12 Diagnostisk fremgangsmåde DK2129391T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0711327.7A GB0711327D0 (en) 2007-06-12 2007-06-12 Diagnostic method
PCT/EP2008/004743 WO2008151808A1 (en) 2007-06-12 2008-06-12 Diagnostic method

Publications (1)

Publication Number Publication Date
DK2129391T3 true DK2129391T3 (da) 2012-06-11

Family

ID=38331957

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08759218.4T DK2129391T3 (da) 2007-06-12 2008-06-12 Diagnostisk fremgangsmåde

Country Status (16)

Country Link
US (3) US8518648B2 (da)
EP (1) EP2129391B1 (da)
JP (1) JP5166522B2 (da)
KR (1) KR101563997B1 (da)
CN (2) CN103543271A (da)
AT (1) ATE548050T1 (da)
AU (1) AU2008261252B2 (da)
BR (1) BRPI0812875B8 (da)
CA (1) CA2690067C (da)
DK (1) DK2129391T3 (da)
ES (1) ES2380875T3 (da)
GB (1) GB0711327D0 (da)
PL (1) PL2129391T3 (da)
PT (1) PT2129391E (da)
SI (1) SI2129391T1 (da)
WO (1) WO2008151808A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
US20100240049A1 (en) 2009-01-16 2010-09-23 Cepheid Methods of Detecting Cervical Cancer
JP5488885B2 (ja) * 2009-10-28 2014-05-14 国立大学法人 東京大学 感染症の疾患マーカー
GB201016161D0 (en) * 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
EP2643483A4 (en) * 2010-11-26 2014-04-30 Immunexpress Pty Ltd DIAGNOSTIC AND / OR SCREENING APPROPRIATIONS AND USES THEREFOR
GB201102108D0 (en) * 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
EP2756118A4 (en) * 2011-09-16 2015-09-16 Cepheid METHOD FOR DETECTING SEPSIS
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
US10761093B2 (en) 2014-10-09 2020-09-01 Texas Tech University System Microdevice for cell separation utilizing activation phenotype
CN109541235A (zh) * 2018-08-19 2019-03-29 重庆早柒天生物科技股份有限公司 肝素结合蛋白和降钙素原二联检测试剂盒及其制备方法
CN113727995A (zh) 2019-04-24 2021-11-30 公益财团法人癌研究会 检测癌的方法和检测试剂
CN111208305B (zh) * 2020-02-16 2023-04-25 重庆翼锋生物科技有限公司 Hbp和pct在败血症诊断试剂制备中的用途
CN111951963B (zh) 2020-07-30 2022-09-02 中翰盛泰生物技术股份有限公司 Hbp在covid-19患者的预后风险预警中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627262A (en) * 1989-07-05 1997-05-06 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US5962241A (en) * 1989-07-28 1999-10-05 The University Of Arizona Monoclonal antibody detection of proteins on sperm related to fertility
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
WO1995028949A1 (en) 1994-04-21 1995-11-02 Novo Nordisk A/S Heparin-binding protein for the treatment of sepsis and processes for its preparation
US5976536A (en) 1995-08-09 1999-11-02 Emory University Neisseria mutants, lipooligosaccharides and immunogenic compositions
US5778895A (en) 1997-01-29 1998-07-14 Uab Research Foundation Method of discriminating bacterial from aseptic meningitis
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
WO2003076459A1 (en) 2002-03-08 2003-09-18 Heloise, Anne, Pereira, Ph. D. An early detection marker for chronic inflammatory associated diseases
US7655480B2 (en) * 2002-03-08 2010-02-02 The Board Of Regents Of The University Of Oklahoma Method for predicting sepsis or an acute infectious inflammatory response
EP1581556A2 (en) 2002-08-15 2005-10-05 Leukotech A/S Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp)
AU2003261387A1 (en) * 2003-02-24 2004-09-17 Gtc Biotherapeutics, Inc. Methods of tangential flow filtration and an apparatus therefore
US7191068B2 (en) 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
WO2004112713A2 (en) 2003-06-20 2004-12-29 Royer Biomedical, Inc. Drug polymer complexes
US20070269437A1 (en) 2003-09-19 2007-11-22 Leukotech A/S Pro-Inflammatory and Anti-Inflammatory Antibodies Against the Heparin-Binding Protein (Hbp)
US20050196817A1 (en) * 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
EP1869463A4 (en) * 2005-04-15 2010-05-05 Becton Dickinson Co SEPSIS DIAGNOSIS
AU2006299417A1 (en) * 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in Systemic Inflammatory Response Syndromes
FR2894675B1 (fr) 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method

Also Published As

Publication number Publication date
CA2690067A1 (en) 2008-12-18
KR20100021578A (ko) 2010-02-25
US8518648B2 (en) 2013-08-27
EP2129391A1 (en) 2009-12-09
GB0711327D0 (en) 2007-07-25
JP2010529468A (ja) 2010-08-26
SI2129391T1 (sl) 2012-07-31
CN101687023A (zh) 2010-03-31
CN103543271A (zh) 2014-01-29
BRPI0812875B8 (pt) 2022-07-12
US20100305185A1 (en) 2010-12-02
EP2129391B1 (en) 2012-03-07
CA2690067C (en) 2023-09-19
AU2008261252A1 (en) 2008-12-18
BRPI0812875A2 (pt) 2014-12-09
PL2129391T3 (pl) 2012-09-28
CN101687023B (zh) 2016-04-20
WO2008151808A1 (en) 2008-12-18
US20130252347A1 (en) 2013-09-26
PT2129391E (pt) 2012-06-06
KR101563997B1 (ko) 2015-10-28
JP5166522B2 (ja) 2013-03-21
ATE548050T1 (de) 2012-03-15
AU2008261252B2 (en) 2013-03-14
US9784741B2 (en) 2017-10-10
BRPI0812875B1 (pt) 2017-12-05
US20140187503A1 (en) 2014-07-03
ES2380875T3 (es) 2012-05-21

Similar Documents

Publication Publication Date Title
DK2129391T3 (da) Diagnostisk fremgangsmåde
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
CY1120434T1 (el) Πρωτεϊνες προσδεσης il-1
CR11179A (es) Anticuerpos humanizados contra el globometro ab (20-42) y sus usos
EA200971131A1 (ru) Биомаркеры для прогнозирования чувствительности или отсутствия чувствительности к анти-фно агентам
EA201070270A1 (ru) Пептиды с пониженным уровнем образования димеров
EA200970603A1 (ru) Антагонисты активин-actrii и их применения для повышения уровней эритроцитов
DOP2011000274A (es) Proteinas de union a il-17
UY34736A (es) ?compuestos de indol e indazol que activan la ampk?.
MA30497B1 (fr) Anticorps et immunco-conjugues, et leurs utilisations.
CO6450665A2 (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
EA201270553A1 (ru) Ингибиторы тирозинкиназы брутона
EA200701918A1 (ru) Белок липокалин
CU20120095A7 (es) Antagonistas de pcsk9
CY1112912T1 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
MA34521B1 (fr) Polypeptides de relaxine modifiés et leurs utilisations
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
WO2015070001A3 (en) Compositions and methods for detecting and/or treating inflammation
MA44550B1 (fr) Anticorps anti-acide téichoique de la paroi cellulaire et conjugués associés
NO20084320L (no) Antistoffer mot EGFL7 og fremgangsmater for anvendelse av disse
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ATE549638T1 (de) 13c-mr-bildgebung oder spektroskopie von zelltod
GB201102108D0 (en) Diagnostic method
HK1112928A1 (en) Cspcna isoform modifications and uses thereof
BR112017000490A2 (pt) componente condutor de fluxo